Dopamine Agonists - Pharmacology
Research News and Information

Saturday, November 21, 2009

The time course of dopamine transmission in the ventral tegmental area.

19 Oct 2009 Synaptic transmission mediated by G-protein coupled receptors (GPCR) is not generally thought to be point-to-point. To determine the extent over which dopamine signals in the midbrain, the present study examined the concentration and time course of ... Read more...

Exercise activates redox-sensitive transcription factors and restores renal D1 receptor function in old rats.

14 Sep 2009 We have previously reported that age-associated oxidative stress via protein kinase C (PKC) increases D1 receptor (D1R) phosphorylation and causes D1R-G protein uncoupling in renal proximal tubules (RPTs) of old Fischer 344 rats. This results in ... Read more...

Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency.

23 Aug 2009 OBJECTIVE: To report the efficacy, tolerability, and safety of the dopamine agonist pramipexole in a series of 5 patients affected by inherited 6-pyruvoyl tetrahydropterin synthase (PTPS) deficiency and needing l-3,4 dihydroxyphenylalanine (l-dopa) ... Read more...

Latest indexed articles for 'Dopamine Agonists - Pharmacology'

These are the very latest articles for this heading:

• The time course of dopamine transmission in the ventral tegmental area. 19 Oct 2009
• Exercise activates redox-sensitive transcription factors and restores renal D1 receptor function in old rats. 14 Sep 2009
• Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. 23 Aug 2009
• Dopamine controls persistence of long-term memory storage. 19 Aug 2009
• An ultra-short dopamine pathway regulates basal ganglia output. 17 Aug 2009
• Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function. 12 Aug 2009
• Dopaminergic modulation of olfactory bulb processing affects odor discrimination learning in rats. 30 Jul 2009
• Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa. 21 Jul 2009
• Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model. 16 Jul 2009
• Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors. 29 Jun 2009
• Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. 29 Jun 2009
• Agroclavine potentiates hippocampal EEG effects of weak combined magnetic field in rats. 23 Jun 2009
• Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. 22 Jun 2009
• Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons. 19 Jun 2009
• Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization. 19 Jun 2009
• Dopaminergic modulation of afferent synaptic transmission in the semicircular canals of frogs. 15 Jun 2009
• Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. 15 Jun 2009
• Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling. 15 Jun 2009
• The D(3) dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5. 7 Jun 2009
• Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effects. 3 Jun 2009

See a longer list of these articles.

Technical information about 'Dopamine Agonists'

Definition: Drugs that bind to and activate dopamine receptors.

Registry Number: 0

Descriptor UI: D018491

Alternative terms: Dopamine Agonists; Agonists, Dopamine; Receptor Agonists, Dopamine; Dopamine Receptor Agonist; Agonist, Dopamine Receptor; Receptor Agonist, Dopamine; Dopamine Receptor Agonists; Dopaminergic Agonists; Agonists, Dopaminergic; Dopaminergic Agonist; Agonist, Dopaminergic; Agonists, Dopamine Receptor; Dopamine Agonist; Agonist, Dopamine;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.150.151; D27.505.696.577.150.151;

Online Note: use DOPAMINERGIC AGENTS to search DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS 1989-94

History Note: 95; DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94

Technical Notes: GEN or unspecified; prefer specifics; DF: DOPAMINE AGON or DOPAMINE AG